Trial Profile
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Comparing a 2.2mg 17 Beta-Estradiol/0.69mg Levonorgestrel Combination Transdermal Patch, and a 1mg 17 Beta-Estradiol Transdermal Patch With a Placebo Patch in Postmenopausal Women to Determine the Lowest Effective Dose of Estradiol for the Relief of Moderate to Severe Hot Flushes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2009
Price :
$35
*
At a glance
- Drugs Estradiol (Primary) ; Estradiol/levonorgestrel (Primary)
- Indications Hot flashes; Menopause
- Focus Therapeutic Use
- 02 Jun 2009 Additional lead trial centre, sponsor, affiliate (Bayer) added as reported by ClinicalTrials.gov.
- 02 Jun 2009 Actual end date (Feb 2006) added as reported by ClinicalTrials.gov.
- 01 Oct 2007 Results (including primary endpoint) have been published